You are here
Clinical Trials: Eye Disease
Each Clinical Trial will open in a new browser window or tab.
Conditions: Neurologic Disorders; Nervous System Diseases; Neurodegenerative Diseases; Neurological Disorders; Stroke; Traumatic Brain Injury; Cadasil; Chronic Traumatic Encephalopathy; Cerebral Infarction; Cerebral Ischemia; Cerebral Stroke; Cerebral Hemorrhage; Parkinson; Multi-System Degeneration; MSA - Multiple System Atrophy; Progressive Supranuclear Palsy; ALS; Amyotrophic Lateral Sclerosis; Neuropathy; Diabetic Neuropathies
Interventions: Procedure: Intravenous BMSC; Procedure: Intranasal BMSC
Sponsors: MD Stem Cells; The Healing Institute
Recruiting
Interventions: Procedure: Intravenous BMSC; Procedure: Intranasal BMSC
Sponsors: MD Stem Cells; The Healing Institute
Recruiting
Condition: Dry Age-related Macular Degeneration
Intervention: Biological: retinal pigment epithelium transplantation
Sponsors: Chinese Academy of Sciences; Beijing Tongren Hospital
Recruiting - verified December 2016
Intervention: Biological: retinal pigment epithelium transplantation
Sponsors: Chinese Academy of Sciences; Beijing Tongren Hospital
Recruiting - verified December 2016
Conditions: Age Related Macular Degeneration; Stargardt's Disease; Exudative Age-related Macular Degeneration
Interventions: Procedure: injection of hESC-RPE in suspension; Procedure: injection hESC-RPE seeded in a substrate
Sponsor: Federal University of São Paulo
Recruiting - verified September 2016
Interventions: Procedure: injection of hESC-RPE in suspension; Procedure: injection hESC-RPE seeded in a substrate
Sponsor: Federal University of São Paulo
Recruiting - verified September 2016
Condition: Retinitis Pigmentosa
Intervention: Biological: Stem Cell Transplantation
Sponsor: Stem Cells Arabia
Recruiting - verified February 2016
Intervention: Biological: Stem Cell Transplantation
Sponsor: Stem Cells Arabia
Recruiting - verified February 2016
Conditions: Macular Degeneration; Stargardt's Macular Dystrophy
Intervention: Procedure: Subretinal transplantation
Sponsor: Southwest Hospital, China
Recruiting - verified April 2016
Intervention: Procedure: Subretinal transplantation
Sponsor: Southwest Hospital, China
Recruiting - verified April 2016
Condition: Optic Neuropathy
Intervention: Biological: Stem Cells
Sponsor: Stem Cells Arabia
Recruiting
Intervention: Biological: Stem Cells
Sponsor: Stem Cells Arabia
Recruiting
Conditions: Dry Macular Degeneration; Geographic Atrophy
Intervention: Biological: CPCB-RPE1
Sponsor: Regenerative Patch Technologies, LLC
Recruiting - verified January 2016
Intervention: Biological: CPCB-RPE1
Sponsor: Regenerative Patch Technologies, LLC
Recruiting - verified January 2016
Condition: Uveitis
Intervention: Other: intravitreous administration of regulator T-cells
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2015
Intervention: Other: intravitreous administration of regulator T-cells
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2015
Condition: Retinitis Pigmentosa
Intervention: Drug: hRPC
Sponsor: ReNeuron Limited
Recruiting - verified December 2015
Intervention: Drug: hRPC
Sponsor: ReNeuron Limited
Recruiting - verified December 2015
Conditions: Retinal Degeneration; Primary Open-angle Glaucoma
Interventions: Procedure: Intravitreal transplantation of mesenchymal stem cell; Biological: Culture and isolation of autologous bone-marrow mesenchymal stem cells
Sponsors: University of Sao Paulo; Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified December 2014
Interventions: Procedure: Intravitreal transplantation of mesenchymal stem cell; Biological: Culture and isolation of autologous bone-marrow mesenchymal stem cells
Sponsors: University of Sao Paulo; Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified December 2014
